Companies › ZTS
ZOETIS INC (ZTS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001555280 · EDGAR filings · Updated 2026-07-14
ZOETIS INC (ZTS) has reported institutional ownership of 97.3%, with 1,596 institutional managers holding positions valued at $48.2B per the latest 13F reporting period.
Latest updates
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ZOETIS INC has 1,596 institutional holders and institutional ownership of 97.3%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $4.21B | 8.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $3.08B | 6.4% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.83B | 5.9% |
| 4 | STATE STREET CORP | $2.28B | 4.7% |
| 5 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.88B | 3.9% |
| 6 | MORGAN STANLEY | $1.67B | 3.5% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $1.34B | 2.8% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | $1.20B | 2.5% |
| 9 | NORDEA INVESTMENT MANAGEMENT AB | $679.8M | 1.4% |
| 10 | NORTHERN TRUST CORP | $655.6M | 1.4% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 85 transactions (0 buys, 3 sells) across 21 reporting insiders, with a net reported value of −$2.65M.
Debt maturity schedule
Principal coming due by year for ZOETIS INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2027 | 1 | — |
| 2028 | 2 | — |
| 2030 | 1 | — |
| 2032 | 1 | — |
| 2035 | 1 | — |
| 2043 | 1 | — |
| 2047 | 1 | — |
| 2048 | 1 | — |
| 2050 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Related companies
REGENERON PHARMACEUTICAL (REGN) · HCA HEALTHCARE INC (HCA) · 3M CO (MMM) · ALNYLAM PHARMACEUTICALS INC (ALNY) · BECTON DICKINSON & CO (BDX) · EDWARDS LIFESCIENCES CORP (EW)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.